Scottish Widows Begins Investing Workplace Pension Savings in UK Venture Growth, With IP Group Managing the Portfolio and Four Companies Expected First

Scottish Widows announced on 2 November 2026 the first investments through its UK venture growth portfolio, which sits inside the CG Scottish Widows Growth Long-Term Asset Fund, known as an LTAF. The portfolio is aimed at UK science and technology companies. Aberdeen Investments, which manages the growth sub-fund, has appointed IP Group to run the venture portfolio. The size of the allocation was not disclosed, so we cannot say how much workplace pension money is going in. What the announcement does show is a route: a UK pension provider is sending members' savings into UK venture growth through a manager that picks the companies, and that changes who a fund manager needs to talk to.

What was announced

Scottish Widows said the fund is among the first UK pension schemes to actively allocate members' capital to UK venture growth. The initial investments are expected to include Oxford Quantum Circuits and Quantum Motion, both developing quantum computing, Nyobolt, which makes ultra-fast-charging batteries, and Genomics Limited, which applies AI, machine learning and genetic data to preventative healthcare and drug discovery. The word expected matters, because the announcement describes these as initial investments that are expected, not as closed rounds with disclosed terms. The partners said the mandate is meant to address a shortage of follow-on funding for UK companies that are trying to commercialise and expand. Aberdeen's head of private markets solutions, Nalaka De Silva, said the partnership turns "intent into investment", and Scottish Widows' chief investment officer, Peter Fitzgerald, said pension savers should be able to benefit from growth and innovation in the UK.

The numbers

The announcement gives a count and no amounts. Four companies are named as expected first investments, spread across three themes: two in quantum computing, one in advanced batteries and one in AI-enabled healthcare. By count of named companies that is 50% quantum computing, 25% batteries and 25% healthcare, and we cannot give the split by capital because no amounts were published. The announcement also does not say how many further companies are planned, what share of the LTAF the venture portfolio will take, or how large the first cheques are. Until those figures are disclosed, any estimate of the venture sleeve would be a guess, so we do not offer one. The amount is undisclosed.

How it compares

Another UK workplace scheme moved earlier. Nest announced on 8 July 2026 that it would create a dedicated venture capital sleeve managed by Schroders Capital, starting at £200 million and possibly reaching about £1 billion by 2030 if enough high-quality opportunities appear. Nest's route is a sleeve run by one manager, while Scottish Widows' route is a sub-fund inside an LTAF with a second manager appointed beneath the first. Both go through an intermediary. We also reported that UK pension providers hold £22.1 billion in private markets under the Mansion House Accord, which is 6.6% of growth-phase defined contribution assets against a 10% goal for 2030, and that UK venture funds raised a record $6.9 billion in the third quarter. In our reading, supply of venture capital is rising while a large pool of workplace pension money still has to be placed, and announcements like this one are how that gap starts to close.

The named LP

Scottish Widows is a UK provider of workplace pensions, and its profile sits among limited partners in the UK on FundLinx. The announcement does not give assets under management for the venture portfolio, a typical ticket, or any record of backing first-time funds, so we do not estimate them and we offer no Fund I or Fund II view. What it does give is the structure: the pension provider sets the idea, Aberdeen runs the sub-fund, and IP Group runs the venture portfolio. For a GP, the practical decision makers are the managers, not a pension investment committee.

What a GP should do

This section is our advice, not guidance from Scottish Widows. First, read the structure before you write to anyone: investment decisions in the venture portfolio sit with IP Group, appointed by Aberdeen, so a note to the pension provider will not move a decision. Second, if you run a venture growth fund with UK exposure, ask whether IP Group invests alongside funds in rounds. The mandate is described as filling a gap in follow-on funding, so co-investment is a likelier fit than a fund commitment, although nothing published says whether it commits to outside funds. Third, if one of your portfolio companies works in quantum computing, batteries or AI-enabled health and needs a follow-on round, a warm introduction to IP Group is a concrete reason to talk. Fourth, expect the questions that a pension-backed portfolio asks about valuation policy, reporting frequency and routes to a sale or listing, because the money belongs to workplace savers. Fifth, do not assume the Nest numbers carry over, since Scottish Widows has not published a target.

What to watch next

Watch for the size of the allocation, for further named companies, and for other UK workplace providers announcing their own venture programmes. Our companion playbook sets out how to pitch a workplace pension that invests through intermediaries. FundLinx members can see which institutions are allocating in your strategy.

FundLinx Intelligence | FundLinx.ai